Investment
Features
FeesSafety
Academy
More
Pluang+

Oscar Health stock doubles since April, still undervalued with strong growth outlook

Analyst Insights
24 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Oscar Health's stock has surged over 100% since April, significantly outperforming the market. Despite this rally, the stock trades at a forward price-to-sales ratio of about 0.50, indicating it may be undervalued by more than 80% compared to its sector peers. The company shows strong revenue growth, margin expansion, and improving profitability, making it an attractive buy. Although short interest is high, reflecting some market skepticism, structural risks appear limited, and Oscar Health offers a compelling diversification opportunity for investors.

More News (OSCR)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App